课题基金 / 基金详情

Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)

Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)
海湾南部少数民族/服务不足的临床试验网络(海湾南部 M/U CTN)
批准号:
10227761
负责人:
AUGUSTO C. OCHOA
金额:
$257.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2025-07-31

项目摘要

项目成果

AUGUSTO C. OCHOA的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 海湾南部少数民族/服务不足者- NCORP(GS-M/U-NCORP)和Ochsner社区-NCORP, 路易斯安那州的两个NCORPs都达到了上一个资助周期提出的目标, 并显著增加了路易斯安那州和海湾地区参与临床试验的患者数量 南区。这些成功的NCORPs同意联合起来组成海湾南部 少数/服务不足的临床试验网络(海湾南部M/U CTN)NCORP,将其主要 附属机构路易斯安那州立大学-新奥尔良癌症中心(LSU-CC-新奥尔良),路易斯安那州立大学- Feist Weiller癌症中心 什里夫波特(LSU-FWCC-什里夫波特)、玛丽伯德帕金斯癌症中心(MBPCC)和奥克斯纳癌症中心 中心(Ochsner)。新的海湾南部M/U CTN将为>50%的人提供癌症护理和临床试验 增加该地区新的癌症病例,将提供临床试验的网站数量从22个增加到42个, 并超过参与NCORP试验的少数民族患者所需的30%比例。海湾南部 M/U CTN将带来额外的资源,包括路易斯安那州肿瘤SEER登记(LTR-SEER)和 全州范围的癌症筛查计划,如路易斯安那州乳腺和宫颈健康计划(LBCHP), 路易斯安那州综合癌症控制计划(LCCCP)此外,我们将受益于持续的 研究由我们的研究人员领导,旨在了解我们地区的癌症不平等和差异。 新的海湾南部M/U CTN还扩大了与该地区主要医疗服务提供者的网络 包括退伍军人管理医院(新奥尔良),妇女医院(最大的专门临床 巴吞鲁日妇女健康中心)和基督健康社区站点。新海湾南部M/U CTN已经获得了路易斯安那州卫生部长和州长的支持,他们是 为该州制定一项癌症护理计划(路易斯安那州针对癌症合作组织-TACL),其中 墨西哥湾南部M/U CTN是全州癌症临床试验的主要提供者。这种支持将帮助我们 继续增加患者参与NCORP和非NCORP研究。为了实现我们的目标, 将实施以下三项战略。1.通过更多的伙伴关系扩大网站数量 与社区组织,如CIMHC的,我们将测试新的方法,以增加 社区医生参与为该地区癌症患者提供护理; 2.支持 由我们的研究人员发起的CCDR和健康差异研究的发展,以了解 癌症在我们地区造成的不平等; 3.增加我们对国家试验的参与, NCORP和其他组织,以扩大为我们的患者提供的试验的范围和深度。
英文摘要
ABSTRACT The Gulf South Minority/Underserved – NCORP (GS-M/U-NCORP) and the Ochsner-Community-NCORP, the two NCORPs in Louisiana, have both met the objectives proposed for the last funding cycle, expanding access to and significantly increasing the number of patients participating in clinical trials in Louisiana and the Gulf South region. These successful NCORPs have agreed to come together to form the Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN) NCORP, which will have as its primary affiliates the LSU – Cancer Center New Orleans (LSU-CC-New Orleans), LSU – Feist Weiller Cancer Center Shreveport (LSU-FWCC-Shreveport), Mary Bird Perkins Cancer Center (MBPCC) and the Ochsner-Cancer Center (Ochsner). The new Gulf South M/U CTN will provide cancer care and access to clinical trials for >50% of new cancer cases in the region, expand the number of sites offering access to clinical trials from 22 to 42, and exceed the required 30% proportion of minority patients participating in NCORP trials. The Gulf South M/U CTN will bring additional resources including the Louisiana Tumor SEER registry (LTR-SEER) and the state-wide cancer screening programs such as the Louisiana Breast and Cervical Health Program (LBCHP), and the Louisiana Comprehensive Cancer Control Program (LCCCP). In addition we will benefit from ongoing research led by our investigators and aimed at understanding cancer inequities and disparities in our region. The new Gulf South M/U CTN has also expanded its network with major health providers in the region including the Veterans Administration Hospital (New Orleans), Woman's Hospital (the largest dedicated clinical center for women's health) in Baton Rouge and the Christus Health community sites. The new Gulf South M/U CTN has garnered the support of the Louisiana Department of Health Secretary and the Governor, who are developing a cancer care plan for the state (Taking Aim at Cancer in Louisiana Collaborative -TACL), where the Gulf South M/U CTN is the major provider of state-wide cancer clinical trials. This support will help us to continue increasing the participation of patients in NCORP and non-NCORP studies. To achieve our goals we will implement the following three strategies. 1. Expand the number of sites through additional partnerships with community organizations such as FQHC's where we will test novel approaches to increase the participation of community physicians providing care to cancer patients in the region; 2. Support the development of CCDR and Health Disparities research initiated by our investigators to understand the inequities created by cancer in our region and 3. Increase our participation in national trials supported by NCORP and other organizations to expand the scope and depth of trials offered to our patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
  • 批准号:
    10005249
  • 项目类别:
  • 资助金额:
    $20.78万
  • 财政年份:
    2018
  • 负责人:
    AUGUSTO C. OCHOA
  • 依托单位:
Project 2-Metabolic Modulation of Myeloid-Derived Suppressor Cells to Increase Efficacy of Neo adjuvant Chemotherapy and Immunotherapy
  • 批准号:
    10005254
  • 项目类别:
  • 资助金额:
    $27.1万
  • 财政年份:
    2018
  • 负责人:
    AUGUSTO C. OCHOA
  • 依托单位:
Cellular Immunology Metabolism Core
  • 批准号:
    10618085
  • 项目类别:
  • 资助金额:
    $10.62万
  • 财政年份:
    2017
  • 负责人:
    AUGUSTO C. OCHOA
  • 依托单位:
Cell Immunology and Metabolism Core (CIMC)
  • 批准号:
    10223346
  • 项目类别:
  • 资助金额:
    $2.28万
  • 财政年份:
    2017
  • 负责人:
    AUGUSTO C. OCHOA
  • 依托单位:
海外基金